Simvastatin interactions with other drugs (Q37993600)

26 August 2017

title

Simvastatin interactions with other drugs (English)

1 reference

26 August 2017

1 reference

Matilda Florentin

1 reference

26 August 2017

Moses S Elisaf

series ordinal

1 reference

26 August 2017

language of work or name

English

0 references

publication date

15 March 2012

1 reference

Expert Opinion on Drug Safety

26 August 2017

published in

1 reference

26 August 2017

1 reference

26 August 2017

1 reference

26 August 2017

page(s)

439-444

1 reference

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Safety of statins: focus on clinical pharmacokinetics and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Role of P-glycoprotein in statin drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Impact of OATP transporters on pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Breast cancer resistance protein in pharmacokinetics and drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

ACC/AHA/NHLBI clinical advisory on the use and safety of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Statin myopathy: A common dilemma not reflected in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Statin safety: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Mechanistic studies on metabolic interactions between gemfibrozil and statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Simvastatin-induced rhabdomyolysis following cyclosporine treatment for uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

The interaction of diltiazem with simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Simvastatin-induced myopathy, the role of interaction with diltiazem and genetic predisposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Interaction between amlodipine and simvastatin in patients with hypercholesterolemia and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Studies to investigate the pharmacokinetic interactions between ranolazine and ketoconazole, diltiazem, or simvastatin during combined administration in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Rhabdomyolysis in a patient receiving ranolazine and simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Interaction between statins and clopidogrel: is there anything clinically relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Thienopyridines and statins: assessing a potential drug-drug interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Lack of clopidogrel-statin interaction in patients undergoing coronary stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Nonresponders to clopidogrel: pharmacokinetics and interactions involved.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Presumed interaction of fusidic acid with simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Rhabdomyolysis Associated with Simvastatin-Nefazodone Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin with rapamycin plus tacrolimus in liver transplant patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Probable warfarin-simvastatin interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Evaluation of the potential for steady-state pharmacokinetic interaction between vildagliptin and simvastatin in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Coadministration of dalcetrapib with pravastatin, rosuvastatin, or simvastatin: no clinically relevant drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

Lack of pharmacokinetic interaction of mipomersen sodium (ISIS 301012), a 2'-O-methoxyethyl modified antisense oligonucleotide targeting apolipoprotein B-100 messenger RNA, with simvastatin and ezetimibe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.670633

10.1517/14740338.2012.670633

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference